Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Increased expression of ACE2, the SARS-CoV-2 entry receptor, in alveolar and bronchial epithelium of smokers and COPD subjects
Merel Jacobs, Hannelore P. Van Eeckhoutte, Sara Wijnant, et al.
European Respiratory Journal (2020) Vol. 56, Iss. 2, pp. 2002378-2002378
Open Access | Times Cited: 85

Showing 1-25 of 85 citing articles:

Mechanisms of SARS-CoV-2 entry into cells
Cody B. Jackson, Michael Farzan, Bing Chen, et al.
Nature Reviews Molecular Cell Biology (2021) Vol. 23, Iss. 1, pp. 3-20
Open Access | Times Cited: 2532
ACE2: The Major Cell Entry Receptor for SARS-CoV-2
Filippo Scialò, Aurora Daniele, Felice Amato, et al.
Lung (2020) Vol. 198, Iss. 6, pp. 867-877
Open Access | Times Cited: 443
Comorbidities, multimorbidity and COVID-19
Clark D Russell, Nazir Lone, J. Kenneth Baillie
Nature Medicine (2023) Vol. 29, Iss. 2, pp. 334-343
Open Access | Times Cited: 257
On the whereabouts of SARS-CoV-2 in the human body: A systematic review
Wim Trypsteen, Jolien Van Cleemput, Willem van Snippenberg, et al.
PLoS Pathogens (2020) Vol. 16, Iss. 10, pp. e1009037-e1009037
Open Access | Times Cited: 214
Risk of adverse outcomes in patients with underlying respiratory conditions admitted to hospital with COVID-19: a national, multicentre prospective cohort study using the ISARIC WHO Clinical Characterisation Protocol UK
Chloë I. Bloom, Thomas M Drake, Annemarie B Docherty, et al.
The Lancet Respiratory Medicine (2021) Vol. 9, Iss. 7, pp. 699-711
Open Access | Times Cited: 163
ACE2 protein expression in lung tissues of severe COVID-19 infection
Atish Gheware, Animesh Ray, Deeksha Rana, et al.
Scientific Reports (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 77
Smoking patterns and outcomes of severe sars-CoV-2 infection: a retrospective cohort study
Branko Beronja, Aleksandra Karan, Biljana Lukić, et al.
Monaldi Archives for Chest Disease (2025)
Open Access | Times Cited: 2
Chronic obstructive pulmonary disease and COVID-19: interrelationships
Dave Singh, Alexander G. Mathioudakis, Andrew Higham
Current Opinion in Pulmonary Medicine (2021) Vol. 28, Iss. 2, pp. 76-83
Open Access | Times Cited: 76
Age‐related differences in the immune response could contribute to determine the spectrum of severity of COVID‐19
Giorgio Costagliola, Erika Spada, Rita Consolini
Immunity Inflammation and Disease (2021) Vol. 9, Iss. 2, pp. 331-339
Open Access | Times Cited: 70
COVID-19 in Joint Ageing and Osteoarthritis: Current Status and Perspectives
Marianne Lauwers, Man Ting Au, Shuofeng Yuan, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 2, pp. 720-720
Open Access | Times Cited: 50
Human lungs show limited permissiveness for SARS-CoV-2 due to scarce ACE2 levels but virus-induced expansion of inflammatory macrophages
Katja Hönzke, Benedikt Obermayer, Christin Mache, et al.
European Respiratory Journal (2022) Vol. 60, Iss. 6, pp. 2102725-2102725
Open Access | Times Cited: 43
Looking at the Data on Smoking and Post-COVID-19 Syndrome—A Literature Review
Antigona Trofor, Daniela Robu Popa, Oana Melinte, et al.
Journal of Personalized Medicine (2024) Vol. 14, Iss. 1, pp. 97-97
Open Access | Times Cited: 11
Prevalence and risk factors for long COVID among cancer patients: a systematic review and meta-analysis
Hongkun Xu, Tingting Lu, Yajie Liu, et al.
Frontiers in Oncology (2025) Vol. 14
Open Access | Times Cited: 1
Electronic Cigarette Aerosol Is Cytotoxic and Increases ACE2 Expression on Human Airway Epithelial Cells: Implications for SARS-CoV-2 (COVID-19)
Kielan Darcy McAlinden, Wenying Lu, Parisa Vahidi Ferdowsi, et al.
Journal of Clinical Medicine (2021) Vol. 10, Iss. 5, pp. 1028-1028
Open Access | Times Cited: 53
SARS-CoV-2 Infection and Oral Health: Therapeutic Opportunities and Challenges
Christopher J. Coke, Brandon Davison, Niariah Fields, et al.
Journal of Clinical Medicine (2021) Vol. 10, Iss. 1, pp. 156-156
Open Access | Times Cited: 46
Recent advances in respiratory immunization: A focus on COVID-19 vaccines
Xiyue He, Xiaohong Chen, Hairui Wang, et al.
Journal of Controlled Release (2023) Vol. 355, pp. 655-674
Open Access | Times Cited: 23
Angiotensin-converting enzyme 2 and COVID-19: patients, comorbidities, and therapies
Girish Pathangey, Priyal Fadadu, Alexandra R. Hospodar, et al.
AJP Lung Cellular and Molecular Physiology (2020) Vol. 320, Iss. 3, pp. L301-L330
Open Access | Times Cited: 46
Clinical risk factors for mortality in patients with cancer and COVID-19: a systematic review and meta-analysis of recent observational studies
Liu Yang, Huan Lu, Wei Wang, et al.
Expert Review of Anticancer Therapy (2020) Vol. 21, Iss. 1, pp. 107-119
Closed Access | Times Cited: 40
COVID-19, COPD, and AECOPD: Immunological, Epidemiological, and Clinical Aspects
Francesca Polverino, Farrah Kheradmand
Frontiers in Medicine (2021) Vol. 7
Open Access | Times Cited: 36
Nicotine upregulates ACE2 expression and increases competence for SARS-CoV-2 in human pneumocytes
Fabrizio Maggi, Alfredo Rosellini, Pietro Giorgio Spezia, et al.
ERJ Open Research (2021) Vol. 7, Iss. 2, pp. 00713-2020
Open Access | Times Cited: 35
COVID-19 infection in patients with chronic obstructive pulmonary disease: From pathophysiology to therapy. Mini-review
Mónika Fekete, Z Szarvas, Vince Fazekas‐Pongor, et al.
Physiology International (2022) Vol. 109, Iss. 1, pp. 9-19
Open Access | Times Cited: 25
Long COVID among US adults from a population-based study: Association with vaccination, cigarette smoking, and the modifying effect of chronic obstructive pulmonary disease (COPD)
Olufemi Erinoso, Olatokunbo Osibogun, Siva Balakrishnan, et al.
Preventive Medicine (2024) Vol. 184, pp. 108004-108004
Closed Access | Times Cited: 6
Comprehensive in silico identification of impacts of ACE2 SNPs on COVID-19 susceptibility in different populations
Alireza Paniri, Mohammad Mahdi Hosseini, Mojtaba Moballegh-Eslam, et al.
Gene Reports (2020) Vol. 22, pp. 100979-100979
Open Access | Times Cited: 35
COVID-19 and the lungs: A review
Wen‐Lin Su, Kuo‐Cheng Lu, Chih-Yu Chan, et al.
Journal of Infection and Public Health (2021) Vol. 14, Iss. 11, pp. 1708-1714
Open Access | Times Cited: 31
Angiotensin-Converting Enzyme 2 Expression and Severity of SARS-CoV-2 Infection
Sarah Alabsi, Atharva Dhole, Sameh Hozayen, et al.
Microorganisms (2023) Vol. 11, Iss. 3, pp. 612-612
Open Access | Times Cited: 12
Page 1 - Next Page

Scroll to top